Butyric Acid

Butyric acid, also called butanoic acid, is a straight-chain fatty acid with four carbon atoms and one of the smallest of the short-chain fatty acids commonly discussed in nutrition. At the pH of the body it is almost entirely present as its negatively charged form, butyrate ^[1]. It is an oily liquid with a characteristically rancid smell and occurs naturally in butter, where it appears as the triglyceride tributyrin, as well as in milk and cheese; it was first isolated from butter by the French chemist Michel Eugene Chevreul in the early nineteenth century, and its name derives from the Greek word for butter. In the human body, most butyrate is generated in the large intestine when anaerobic gut bacteria ferment dietary fiber and resistant starch ^[1][3].

Butyrate has drawn intense scientific interest because of its central role in the gut. It is the preferred fuel for colonocytes, the cells lining the colon, supplying much of their energy, and it helps maintain the intestinal barrier, supports mucosal immunity, and exerts anti-inflammatory effects ^[1][3]. Depletion of butyrate-producing bacteria has been linked to a range of conditions, and reviews have examined butyrate in inflammatory bowel disease, colon cancer, and the gut-brain axis, as well as its possible metabolic benefits in obesity and type 2 diabetes ^[2][3][5].

At the molecular level, butyrate acts in two main ways. It inhibits histone deacetylases, enzymes that remove acetyl groups from histone proteins, thereby influencing which genes are switched on and off; and it activates several G-protein-coupled receptors that sense short-chain fatty acids ^[1][4]. Through these actions it can alter cell proliferation, immune signaling, and gene expression in the gut and elsewhere in the body ^[4].

Beyond the butyrate the body makes for itself, butyric acid is sold as a dietary supplement, usually as salts such as sodium butyrate or calcium butyrate, or as the ester tributyrin, taken in an effort to raise butyrate levels or support gut health. Clinical attempts to increase butyrate in people have produced mixed results, and it remains an active area of research rather than an approved treatment for most conditions ^[3][5].

Butyric acid (butyrate) is a short-chain fatty acid and HDAC inhibitor used as a gut-health supplement; oral use commonly causes gastrointestinal effects such as bloating, cramping and nausea, and it has a strong, unpleasant odor. It is generally tolerated in supplemental amounts, but long-term and high-dose human safety data are limited, and its effects in significant gastrointestinal disease are not well characterized.

Butyric acid takes its name from the Latin word for butter, butyrum, reflecting its early isolation from rancid butter by the French chemist Michel Eugene Chevreul in the early nineteenth century. Long recognized as a short-chain fatty acid, it was later understood to be produced in large quantities in the human colon when gut bacteria ferment dietary fiber. Over recent decades interest has shifted from its chemistry to its biology, as researchers identified butyrate as the principal energy source for the cells lining the colon and as a natural inhibitor of histone deacetylase enzymes. It is now widely studied, and supplemented in salt or ester forms, for its roles in gut and metabolic health.

Butyric acid enjoys a strong and growing reputation in gut-health science as one of the most important products of a fiber-rich diet. It is appreciated for its dual character; it both fuels the colonic lining directly and acts as a signaling molecule that helps strengthen the gut barrier and temper inflammation. Research into delivery strategies, such as butyrylated resistant starches that carry butyrate to the colon, reflects genuine enthusiasm for harnessing its benefits. While much of the strongest evidence still comes from cell and animal studies, butyrate is broadly viewed as a promising, naturally occurring supporter of digestive and metabolic wellbeing rather than a quick fix.